Clinical Trial Detail

NCT ID NCT03109015
Title Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing (ASSET)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult senior

No variant requirements are available.